TLDR Index
Daily Editions
Contents
  1. Page 1: Today’s IndexTLDR, TLDR AI, TLDR Web Dev, TLDR InfoSec, TLDR Crypto · 9 stories
  2. Page 2: TLDRTLDR · 7 stories
  3. Page 3: TLDR AITLDR AI · 15 stories
  4. Page 4: TLDR Web DevTLDR Web Dev · 9 stories
  5. Page 5: TLDR InfoSecTLDR InfoSec · 12 stories
  6. Page 6: TLDR CryptoTLDR Crypto · 11 stories
  7. Page 7: TLDR DesignTLDR Design · 11 stories
  8. Page 8: TLDR FoundersTLDR Founders · 12 stories
  9. Page 9: TLDR MarketingTLDR Marketing · 12 stories
  10. Page 10: Resources & ToolsTLDR, TLDR AI, TLDR Web Dev, TLDR InfoSec, TLDR Design, TLDR Founders, TLDR Marketing · 12 stories
  11. Page 11: SponsoredTLDR, TLDR AI, TLDR Web Dev, TLDR InfoSec, TLDR Founders, TLDR Marketing · 10 stories
?
Keyboard shortcuts
← / →
Previous / next page
↑ / ↓
Scroll while full screen
PgUp / PgDn
Scroll by viewport
Space
Scroll down by viewport
Shift+Space
Scroll up by viewport
Home
First page
End
Last page
F
Full screen
Escape
Exit immersive mode

Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

TLDR

SPACEX'S NEXT STARSHIP LAUNCH—AND FIRST CATCH—COULD HAPPEN THIS WEEKEND

SpaceX's Starship rocket could fly again as soon as Sunday. The test is still pending FAA approval. The last public statement released by the FAA suggested the agency didn't expect to determine whether to approve the license before late November, but there is some optimism at SpaceX that it will issue a launch license much sooner. The fifth Starship test flight will attempt the first-ever return to the launch site and catch of the Super Heavy booster. SpaceX won't attempt to reignite Starship's Raptor engines in space on the upcoming flight - the spacecraft will come to a soft splashdown in a target area in the Indian Ocean.

arstechnica.com · 9 min

TLDR

SAMSUNG SAYS IT'S IN “CRISIS,” APOLOGIZES FOR MISSING PROFIT TARGET

Samsung issued a public apology and acknowledged it is in a 'crisis' following the release of its profit guidance on Tuesday. It reported a preliminary profit that undershot market expectations, and its share price has fallen almost 30% over the past six months. The worse-than-expected guidance underlines investor concerns about deteriorating memory market conditions and the possibility of slowing AI investment by big tech groups. Samsung is cutting some of its overseas staff and wrestling with growing worker discontent at home.

arstechnica.com · 3 min

TLDR

GROUNDBREAKING OVARIAN CANCER VACCINE AT AN "EXCITING" MOMENT, LEAD SCIENTIST SAYS

Scientists at Oxford have started developing an ovarian cancer vaccine that imbues the immune system with the ability to recognize and attack early-stage ovarian cancer cells. The research is currently focusing on women with one or two specific mutations known to be linked to a higher risk of breast and ovarian cancer. The vaccine still needs to go through several rounds of trials, a process that could take years, before human clinical trials can begin.

futurism.com · 2 min

TLDR

HOW LONG TIL WE'RE ALL ON OZEMPIC?

The supply of GLP-1 medications like Ozempic has been plagued with shortages. While companies are doing what they can to increase supply, it is extremely unlikely that demand will be met in the near term. This article looks at growth for GLP-1 drugs over the next six years and how many people will stand to benefit from them over this time. More than two in five people in the US are overweight, so increasing access to the drug will have a large benefit on the population.

asteriskmag.com · 24 min

TLDR IndexPage 1